EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C21H46NO4P |
| Net Charge | 0 |
| Average Mass | 407.576 |
| Monoisotopic Mass | 407.31645 |
| SMILES | CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C |
| InChI | InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3 |
| InChIKey | PQLXHQMOHUQAKB-UHFFFAOYSA-N |
| Wikipedia |
|---|
| Roles Classification |
|---|
| Biological Roles: | antifungal agent An antimicrobial agent that destroys fungi by suppressing their ability to grow or reproduce. immunomodulator Biologically active substance whose activity affects or plays a role in the functioning of the immune system. anticoronaviral agent Any antiviral agent which inhibits the activity of coronaviruses. apoptosis inducer Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms. protein kinase inhibitor An EC 2.7.* (P-containing group transferase) inhibitor that interferes with the action of protein kinases. antiprotozoal drug Any antimicrobial drug which is used to treat or prevent protozoal infections. |
| Applications: | immunomodulator Biologically active substance whose activity affects or plays a role in the functioning of the immune system. anti-inflammatory agent Any compound that has anti-inflammatory effects. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antiprotozoal drug Any antimicrobial drug which is used to treat or prevent protozoal infections. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| miltefosine (CHEBI:75283) has role anti-inflammatory agent (CHEBI:67079) |
| miltefosine (CHEBI:75283) has role anticoronaviral agent (CHEBI:149553) |
| miltefosine (CHEBI:75283) has role antifungal agent (CHEBI:35718) |
| miltefosine (CHEBI:75283) has role antineoplastic agent (CHEBI:35610) |
| miltefosine (CHEBI:75283) has role antiprotozoal drug (CHEBI:35820) |
| miltefosine (CHEBI:75283) has role apoptosis inducer (CHEBI:68495) |
| miltefosine (CHEBI:75283) has role immunomodulator (CHEBI:50846) |
| miltefosine (CHEBI:75283) has role protein kinase inhibitor (CHEBI:37699) |
| miltefosine (CHEBI:75283) is a phosphocholines (CHEBI:36700) |
| miltefosine (CHEBI:75283) is a phospholipid (CHEBI:16247) |
| INNs | Source |
|---|---|
| miltefosine | KEGG DRUG |
| miltefosina | ChemIDplus |
| miltefosinum | ChemIDplus |
| miltéfosine | WHO MedNet |
| Synonyms | Source |
|---|---|
| Hexadecylphosphorylcholine | ChemIDplus |
| Hexadecylphosphocholine | ChemIDplus |
| monohexadecylphosphocholine | ChEBI |
| monohexadecylphosphorylcholine | ChEBI |
| Manual Xrefs | Databases |
|---|---|
| D02494 | KEGG DRUG |
| Miltefosine | Wikipedia |
| 1810 | DrugCentral |
| Registry Numbers | Sources |
|---|---|
| Reaxys:3690495 | Reaxys |
| CAS:58066-85-6 | KEGG DRUG |
| CAS:58066-85-6 | ChemIDplus |
| Citations |
|---|